Annual SGA
$5.62 M
-$3.29 M-36.91%
December 31, 2023
Summary
- As of February 7, 2025, ADIL annual SGA is $5.62 million, with the most recent change of -$3.29 million (-36.91%) on December 31, 2023.
- During the last 3 years, ADIL annual SGA has risen by +$546.20 thousand (+10.76%).
- ADIL annual SGA is now -39.85% below its all-time high of $9.34 million, reached on December 31, 2021.
Performance
ADIL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.18 M
-$94.90 K-7.44%
September 30, 2024
Summary
- As of February 7, 2025, ADIL quarterly SGA is $1.18 million, with the most recent change of -$94.90 thousand (-7.44%) on September 30, 2024.
- Over the past year, ADIL quarterly SGA has dropped by -$210.90 thousand (-15.17%).
- ADIL quarterly SGA is now -67.48% below its all-time high of $3.63 million, reached on September 30, 2018.
Performance
ADIL Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$301.73 M
-$13.05 M-4.52%
September 30, 2024
Summary
- As of February 7, 2025, ADIL TTM SGA is -$301.73 million, with the most recent change of -$13.05 million (-4.52%) on September 30, 2024.
- Over the past year, ADIL TTM SGA has dropped by -$306.84 million (-6006.54%).
- ADIL TTM SGA is now -2936.06% below its all-time high of -$9.94 million.
Performance
ADIL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ADIL Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.9% | -15.2% | -6006.5% |
| 3 y3 years | +10.8% | -15.2% | -6006.5% |
| 5 y5 years | -15.1% | -15.2% | -6006.5% |
ADIL Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -39.9% | at low | -54.0% | +12.6% | -74.2% | at low |
| 5 y | 5-year | -39.9% | +31.4% | -57.7% | +33.0% | -326.4% | at low |
| alltime | all time | -39.9% | +2023.5% | -67.5% | +1951.8% | -2936.1% | at low |
Adial Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.18 M(-7.4%) | $5.36 M(+0.5%) |
| Jun 2024 | - | $1.27 M(-8.3%) | $5.34 M(+4.4%) |
| Mar 2024 | - | $1.39 M(-8.5%) | $5.11 M(-9.1%) |
| Dec 2023 | $5.62 M(-36.9%) | $1.52 M(+32.0%) | $5.62 M(-8.9%) |
| Sep 2023 | - | $1.15 M(+9.9%) | $6.17 M(-10.3%) |
| Jun 2023 | - | $1.05 M(-45.0%) | $6.87 M(-18.1%) |
| Mar 2023 | - | $1.90 M(-7.9%) | $8.39 M(-6.2%) |
| Dec 2022 | $8.91 M(-4.7%) | $2.07 M(+11.1%) | $8.95 M(-0.4%) |
| Sep 2022 | - | $1.86 M(-27.5%) | $8.98 M(-5.4%) |
| Jun 2022 | - | $2.56 M(+4.1%) | $9.50 M(+5.3%) |
| Mar 2022 | - | $2.46 M(+17.3%) | $9.02 M(-3.5%) |
| Dec 2021 | $9.34 M(+84.1%) | $2.10 M(-11.5%) | $9.34 M(+8.0%) |
| Sep 2021 | - | $2.37 M(+13.8%) | $8.65 M(+11.3%) |
| Jun 2021 | - | $2.08 M(-25.2%) | $7.77 M(+17.4%) |
| Mar 2021 | - | $2.79 M(+98.2%) | $6.62 M(+30.5%) |
| Dec 2020 | $5.07 M | $1.41 M(-5.6%) | $5.07 M(+11.4%) |
| Sep 2020 | - | $1.49 M(+60.2%) | $4.55 M(+15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $930.80 K(-25.0%) | $3.94 M(-0.4%) |
| Mar 2020 | - | $1.24 M(+39.9%) | $3.96 M(-7.5%) |
| Dec 2019 | $4.28 M(-35.3%) | $887.00 K(+0.6%) | $4.28 M(-3.5%) |
| Sep 2019 | - | $881.50 K(-7.1%) | $4.43 M(-38.2%) |
| Jun 2019 | - | $948.60 K(-39.3%) | $7.18 M(-9.1%) |
| Mar 2019 | - | $1.56 M(+49.9%) | $7.90 M(+19.3%) |
| Dec 2018 | $6.62 M(+713.9%) | $1.04 M(-71.3%) | $6.62 M(+13.2%) |
| Sep 2018 | - | $3.63 M(+117.9%) | $5.85 M(+138.3%) |
| Jun 2018 | - | $1.66 M(+486.1%) | $2.45 M(+152.4%) |
| Mar 2018 | - | $284.00 K(+5.3%) | $972.00 K(+19.5%) |
| Dec 2017 | $813.20 K(+207.2%) | $269.80 K(+15.0%) | $813.10 K(+34.8%) |
| Sep 2017 | - | $234.60 K(+27.8%) | $603.00 K(+40.5%) |
| Jun 2017 | - | $183.60 K(+46.8%) | $429.20 K(+41.6%) |
| Mar 2017 | - | $125.10 K(+109.5%) | $303.10 K(+70.3%) |
| Dec 2016 | $264.70 K(-46.8%) | $59.70 K(-1.8%) | $178.00 K(+50.5%) |
| Sep 2016 | - | $60.80 K(+5.7%) | $118.30 K(+105.7%) |
| Jun 2016 | - | $57.50 K | $57.50 K |
| Dec 2015 | $497.10 K | - | - |
FAQ
- What is Adial Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals annual SGA year-on-year change?
- What is Adial Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals quarterly SGA year-on-year change?
- What is Adial Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals TTM SGA year-on-year change?
What is Adial Pharmaceuticals annual SGA?
The current annual SGA of ADIL is $5.62 M
What is the all time high annual SGA for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high annual SGA is $9.34 M
What is Adial Pharmaceuticals annual SGA year-on-year change?
Over the past year, ADIL annual SGA has changed by -$3.29 M (-36.91%)
What is Adial Pharmaceuticals quarterly SGA?
The current quarterly SGA of ADIL is $1.18 M
What is the all time high quarterly SGA for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high quarterly SGA is $3.63 M
What is Adial Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, ADIL quarterly SGA has changed by -$210.90 K (-15.17%)
What is Adial Pharmaceuticals TTM SGA?
The current TTM SGA of ADIL is -$301.73 M
What is the all time high TTM SGA for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high TTM SGA is -$9.94 M
What is Adial Pharmaceuticals TTM SGA year-on-year change?
Over the past year, ADIL TTM SGA has changed by -$306.84 M (-6006.54%)